PIEIX
Price
$39.89
Change
+$0.81 (+2.07%)
Updated
Jul 31 closing price
Net Assets
7.61B
VEMIX
Price
$36.99
Change
+$0.46 (+1.26%)
Updated
Jul 31 closing price
Net Assets
163.32B
Interact to see
Advertisement

PIEIX vs VEMIX

PIEIX vs VEMIX Comparison Chart in %
View a ticker or compare two or three
VS
PIEIX vs. VEMIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PIEIX is a Buy and VEMIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 163B vs. PIEIX (7.61B). VEMIX pays higher dividends than PIEIX: VEMIX (2.35) vs PIEIX (0.78). PIEIX was incepted earlier than VEMIX: PIEIX (25 years) vs VEMIX (26 years). PIEIX (1.17) is less costly to investors than VEMIX (0.06). PIEIX is a more actively managed with annual turnover of: 32.30 vs. VEMIX (6.00). PIEIX has a lower initial minimum investment than VEMIX: PIEIX (0) vs VEMIX (5000000). PIEIX annual gain was more profitable for investors over the last year : 30.20 vs. VEMIX (19.40). PIEIX return over 5 years is better than : 30.92 vs. VEMIX (27.68).
PIEIXVEMIXPIEIX / VEMIX
Total Expense Ratio1.110.061,850%
Annual Report Gross Expense Ratio1.170.061,950%
Fund Existence25 years26 years-
Gain YTD16.4339.135180%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.61B163B5%
Annual Yield % from dividends0.782.3533%
Returns for 1 year30.2019.40156%
Returns for 3 years66.8746.57144%
Returns for 5 years30.9227.68112%
Returns for 10 years106.1589.54119%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMYZX52.160.31
+0.60%
Putnam Core Equity Fund R
TCMGX18.850.04
+0.21%
Nuveen Quant Mid Cap Growth A
VRSCX26.65-0.22
-0.82%
Voya SmallCap Opportunities Port R6
PGRUX10.67-0.09
-0.84%
Principal Global Real Estate Sec R5
LHCAX23.22-0.40
-1.69%
Lord Abbett Health Care A